Tevard Biosciences is a biotechnology company that focuses on developing lifelong cures for patients with rare genetic diseases. Founded by renowned MIT molecular cell biologist Professor Harvey Lodish, along with Daniel Fischer and Warren Lammert, the company operates as a Contract Manufacturing Organisation (CMO) and Contract Development and Manufacturing Organisation (CDMO) to provide essential support to the pharmaceutical industry.

Services include:
- Gene therapy development
- AAV (adeno-associated virus) production
- Process development
- Analytical testing
- Quality assurance
- Regulatory support

Tevard Biosciences is committed to advancing the field of genetic medicine and providing innovative solutions for the treatment of rare diseases. For more information, visit tevard.com.